EGF and lung adenocarcinoma: Treatment of human lung adenocarcinoma A549 cell line with SP-D has been shown to suppress the epidermal growth factor (EGF) signaling by interrupting the EGF–EGFR interaction, thus reducing cell proliferation, invasion, and migration (22).